Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Amphastar P

Current price
57.92 USD +1.6 USD (+2.84%)
Last closed 56.32 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 2 774 796 544 USD
Yield for 12 month +97.28 %
21.11.2021 - 28.11.2021

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API). It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation; and Vasopressin to increase blood pressure in adults with vasodilatory shock. Further, the company distributes recombinant human insulin APIs and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Address: 11570 6th Street, Rancho Cucamonga, CA, United States, 91730


WallStreet Target Price

66.5 USD

P/E ratio


Dividend Yield

Current Year

+498 987 000 USD

Last Year

+437 768 000 USD

Current Quarter

+180 556 000 USD

Last Quarter

+145 712 000 USD

Current Year

+248 860 000 USD

Last Year

+199 739 000 USD

Current Quarter

+108 403 000 USD

Last Quarter

+72 738 000 USD

Key Figures AMPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 215 639 008 USD
Operating Margin TTM 40.25 %
PE Ratio 22.625
Return On Assets TTM 10.1 %
PEG Ratio 2.77
Return On Equity TTM 24.59 %
Wall Street Target Price 66.5 USD
Revenue TTM 601 313 024 USD
Book Value 12.43 USD
Revenue Per Share TTM 12.44 USD
Dividend Share
Quarterly Revenue Growth YOY 50.3 %
Dividend Yield
Gross Profit TTM 248 860 000 USD
Earnings Share 2.56 USD
Diluted Eps TTM 2.56 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY 203.3 %
Profit Margin 22.5 %

Dividend Analytics AMPH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AMPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AMPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 22.625
Forward PE
Enterprise Value Revenue 5.2359
Price Sales TTM 4.6146
Enterprise Value EBITDA 13.9754
Price Book MRQ 4.664

Financials AMPH

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators AMPH

For 52 weeks

27.58 USD 67.66 USD
50 Day MA 49.13 USD
Shares Short Prior Month 2 502 884
200 Day MA 47.33 USD
Short Ratio 7.21
Shares Short 2 891 180
Short Percent 9.56 %